以上内容来自Benzinga Earnings专栏,原文如下:
TG Therapeutics (NASDAQ:TGTX) reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. This is a 250 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $108.19 million which beat the analyst consensus estimate of $99.95 million by 8.24 percent. This is a 146.04 percent increase over sales of $43.97 million the same period last year.
精彩评论